Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Melphalan-associated pulmonary toxicity following high-dose therapy with autologous hematopoietic stem cell transplantation

Bone Marrow Transplantation volume 26, pages 1107–1109 (2000)Cite this article

Abstract

Melphalan can rarely cause interstitial pneumonitis and fibrosis. Although it has been reported previously in patients after conventional doses, we report four cases developing diffuse interstitial pneumonitis (DIP) after high-dose melphalan-based therapy. In a 3-year period, four of 57 (7%) consecutive patients undergoing high-dose melphalan (200 mg/m2; MEL 200) were identified with DIP. Two patients who were heavily pre-treated with alkylators developed progressive respiratory failure despite high-dose steroids and eventually died. The other two patients previously treated with vincristine, adriamycin, and dexamethasone (VAD) improved dramatically on high-dose steroids with complete resolution of their pneumonitis. Melphalan should be added to the growing list of alkylators causing pulmonary toxicity. Bone Marrow Transplantation (2000) 26, 1107–1109.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Calabresi P, Parks R . Alkylating agents, antimetabolites, hormones, and other antiproliferative agents. In: Goodman LS, Gilman A (eds) Pharmacologic Basis of Therapeutics Macmillan: Toronto 1975 1348–1359

    Google Scholar 

  2. Gillett DG, Ford GT . Drug-induced lung disease. In: Thurlbeck W (ed) The Lung Structure, Function and Disease Williams and Wilkins: Baltimore 1978 21–42

    Google Scholar 

  3. Codling BW, Chakera TMH . Pulmonary fibrosis following therapy with melphalan for multiple myeloma J Clin Pathol 1972 25: 668–573

    Article  CAS  Google Scholar 

  4. Taetle R, Dickman P, Feldman P . Pulmonary histopathologic changes associated with melphalan therapy Cancer 1978 42: 1239–1245

    Article  CAS  Google Scholar 

  5. Westerfield BT, Michalski JP, McCombs C, Light RW . Reversible melphalan-induced lung damage Am J Med 1980 68: 767–771

    Article  CAS  Google Scholar 

  6. Jones RB, Mathes S, Shpall EJ et al. Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine J Natl Cancer Inst 1993 85: 640–647

    Article  CAS  Google Scholar 

  7. Chan CK, Hyland RH, Hutcheon MA . Pulmonary complications following bone marrow transplantation Clin Chest Med 1990 11: 323–332

    CAS  PubMed  Google Scholar 

  8. Durant JR, Norgard MJ, Murad TM et al. Pulmonary toxicity associated with bischloroethylnitrosurea (BCNU) Ann Intern Med 1979 90: 191–194

    Article  CAS  Google Scholar 

  9. Rosenow EC III, Myers JL, Swensen SJ, Pisani RJ . Drug-induced pulmonary disease. An update Chest 1992 102: 239–250

    Article  Google Scholar 

  10. Malik S, Jeffrey L, Myers J et al. Lung toxicity associated with cyclophosphamide use two distinct patterns Am J Respir Crit Care Med 1996 154: 1851–1856

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA

    MS Akasheh & DH Vesole

  2. Adult Bone Marrow Transplantation Program, University of Texas Health Center and South Texas Veterans Health Care System, San Antonio, TX, USA

    CO Freytes

Authors
  1. MS Akasheh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. CO Freytes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. DH Vesole
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akasheh, M., Freytes, C. & Vesole, D. Melphalan-associated pulmonary toxicity following high-dose therapy with autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 26, 1107–1109 (2000). https://doi.org/10.1038/sj.bmt.1702664

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702664

Keywords

This article is cited by

Search

Advanced search

Quick links